CMS Announces Participants in Landmark Medicaid Drug Payment Model to Bring Down Drug Costs for Most Vulnerable Americans

CMS announced participating states in the GENEROUS Medicaid drug payment model, which it said is designed to lower drug costs and improve access to critical medications for Medicaid beneficiaries. The initiative focuses on payment reform in Medicaid drug purchasing and is framed by CMS as a way to help vulnerable patients obtain needed treatments. The announcement is materially different from previously published rural and workforce-focused access items because it centers on prescription drug affordability and Medicaid policy.